Literature DB >> 11510763

The epidemiology of gastroesophageal reflux disease: what we know and what we need to know.

G Eisen1.   

Abstract

GERD is a common and costly disorder. Despite its prevalence, the epidemiology and natural history of GERD are incompletely understood. Until now, most studies have been of short duration and utilized convenience samples of patients presenting for upper endoscopy. There remain several obstacles, enumerated above, that need to be overcome to better study the epidemiology of GERD. Large scale, prospective data collection with standardized terminology and longitudinal follow-up will allow a clearer picture of the incidence, prevalence, natural history, and complications of GERD. This in turn should lead to timely, cost-effective diagnosis and management of this disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11510763     DOI: 10.1016/s0002-9270(01)02580-1

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

Review 1.  Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.

Authors:  Joan Monés
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Histamine2-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing.

Authors:  Johnson W McRorie; James A Kirby; Philip B Miner
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

3.  Is Toupet fundoplication the procedure of choice for treating gastroesophageal reflux disease? Results of a prospective randomized experimental trial comparing three major antireflux operations in a porcine model.

Authors:  K Bachmann; R Wachowiak; C Rempf; Y Vashist; O Mann; E F Yekebas; J R Izbicki; K A Gawad
Journal:  Surg Endosc       Date:  2011-05-14       Impact factor: 4.584

4.  Counselling by primary care physicians may help patients with heartburn-predominant uninvestigated dyspepsia.

Authors:  Pierre Paré; Joanna Lee; Ian A Hawes
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

5.  Esomeprazole: a review of its use in the management of acid-related disorders in the US.

Authors:  Lesley J Scott; Christopher J Dunn; Gordon Mallarkey; Miriam Sharpe
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Seyed Mehrbod Atshani; Sepideh Chagharvand; Fatemeh Souti
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

7.  Nissen fundoplication has a vagolytic effect on the lower esophageal sphincter.

Authors:  B Sarani; T Chan; R Wise; S Evans
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

8.  Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure.

Authors:  Fabio Pace; Stefano Pallotta; Gianpiero Manes; Annalisa de Leone; Patrizia Zentilin; Luigi Russo; Vincenzo Savarino; Matteo Neri; Enzo Grossi; Rosario Cuomo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

Review 9.  Esomeprazole: a review of its use in the management of acid-related disorders.

Authors:  Lesley J Scott; Christopher J Dunn; Gordon Mallarkey; Miriam Sharpe
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Establishment of animal model of gastroesophageal reflux disease by per-oral endoscopic tunneling: a preliminary study.

Authors:  Hai-Qing Hu; Hui-Kai Li; Ying Xiong; Xiao-Bin Zhang; Jun-Li Zhi; Xiao-Xiao Wang; En-Qiang Linghu
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.